Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2006
03/22/2006CN1246008C Chinese medicine preparation for curing acute and chronic rhinitis and its production method
03/22/2006CN1245997C Suction stick for reducing fever, relieving sore-throat and anti diarrhea
03/22/2006CN1245982C Treatment of asthma and airway diseases
03/22/2006CN1245978C Preventive or therapeutic drugs for various eosinophilia realated diseases containing chymase inhibitors as active ingredient
03/22/2006CN1245973C Use of biochemical material for preparing medicine for preventing and treating disease caused by smooth muscle cell contraction in human organ
03/22/2006CN1245972C Naringenin and its salt used for preparing cough suppressing resolving phlegm medicine
03/22/2006CN1245962C Novel process
03/22/2006CN1245959C Healthy products for regulating blood fat and removing heat from throat
03/21/2006US7015325 Alkyne oxy carbamate derivatives used to treat respiratory system disorders
03/21/2006US7015234 Hydroxamic acid derivatives
03/21/2006US7015229 An antagonist of a corticotropin releasing factor (CRF) receptor, treating central nervous system disorders or anxiety disorders, depression and stress
03/21/2006US7015216 Heteroaryl-β-alanine derivatives as alpha 4 integrin inhibitors
03/21/2006US7015196 neurokinin receptor inhibitors comprising cyclic petides used for prophylaxis of respiratory system and urogenital disorders, as antitussive agents and muscle relaxants
03/21/2006US7014867 Tablet comprising cetirizine and pseudoephedrine
03/21/2006US7014847 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
03/21/2006CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
03/21/2006CA2178949C Morpholine and thiomorpholine tachykinin receptor antagonists
03/16/2006WO2006029142A2 Methods and systems for treating asthma and other respiratory diseases
03/16/2006WO2006028284A1 Morpholine compound
03/16/2006WO2006028239A1 Carbamoyl-substituted spiro derivative
03/16/2006WO2006027579A2 The treatment of inflammatory disorders and pain
03/16/2006WO2006027377A1 Ciclesonide and syk inhibitor combination and methods of use thereof
03/16/2006WO2006026998A1 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
03/16/2006WO2005111002A3 Substituted cycloalkyl derivatives for use in the treatment of respiratory diseases
03/16/2006WO2005110421A3 Aerosol formulation for inhalation of beta agonists
03/16/2006WO2005107873A3 Glycopyrrolate for treating childhood asthma
03/16/2006WO2005107872A3 Treating respiratory diseases with gycopyrrolate and analogues
03/16/2006WO2005085443A3 Rnai-based therapeutics for allergic rhinitis and asthma
03/16/2006US20060058371 Inhibiting pathological activation of the transcription factor NF- kappa B (nuclear factor- kappa B); amino-benzothiophene compounds, therapy of inflammatory and tissue repair disorders; particularly rheumatoid arthritis, inflammatory bowel disease, asthma and chronic obstructive pulmonary disease
03/16/2006US20060058350 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient
03/16/2006US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase
03/16/2006US20060058329 Pyrazole inhibitors of the transforming growth factor
03/16/2006US20060058309 Respiratory syncytial virus replication inhibitors
03/16/2006US20060058304 Azaindole kinase inhibitors
03/16/2006US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide
03/16/2006US20060058299 N-2s-4-3,4-difluorobenzyl morpholin-2yl methyl -2-(3-methylsulphonyl amino!phenyl acetamide as ccr3 antagonist for the treatment of inflammatory conditions
03/16/2006US20060058292 2,4-pyrimidinediamine compounds and their uses
03/16/2006US20060058288 Severe sepsis preventive therapeutic agent
03/16/2006US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen
03/16/2006US20060058246 Macrolide compounds endowed with antiinflammatory activity
03/16/2006US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
03/16/2006US20060057236 Process for producing an extract of ivy leaves
03/16/2006US20060057158 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
03/16/2006DE202005019413U1 Caring and healing ointment, useful for the treatment of dry and/or inflamed nose mucous membrane, comprises a portion of olive oil, rapeseed oil, thistle oil, odorants and an ointment raw material
03/16/2006DE102004043863A1 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum Tablets with place- and time-controlled drug release in the gastrointestinal tract
03/16/2006CA2580019A1 Pharmaceutical composition comprising an isomer of a betamimetic agent and an anti-cholinergic agent
03/16/2006CA2579884A1 Methods for treating local tracheal, bronchial or alveolar bleeding or hemoptysis
03/16/2006CA2579540A1 The treatment of inflammatory disorders and pain
03/16/2006CA2579204A1 Carbamoyl-substituted spiro derivative
03/16/2006CA2579007A1 Ciclesonide and syk inhibitor combination and methods of use thereof
03/16/2006CA2579000A1 Novel 3-thia-10-aza-phenanthrene derivatives
03/16/2006CA2577408A1 Use of (halobenzyloxy) benzylamino-propanamides for the manufacture of medicaments active as sodium and/or calcium channel selective modulators
03/15/2006EP1634953A2 Platelet-activating factor acethylhydrolase
03/15/2006EP1634606A1 Drug for airway administration
03/15/2006EP1634600A1 Antiallergic composition
03/15/2006EP1634597A1 Compositions comprising dextromethorphan and quinidine or quinine for the treatment of emotional lability
03/15/2006EP1634595A1 N-Phenylbenzamide derivatives as drugs for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
03/15/2006EP1634594A1 Use of 3-substituted oxindole derivatives as KCNQ potassium channel modulators
03/15/2006EP1634081A2 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
03/15/2006EP1633776A1 MODIFIED i BORDETELLA /i ADENYLATE CYCLASE COMPRISING OR LACKING CD11b/CD18 INTERACTION DOMAIN AND USES THEREOF
03/15/2006EP1633744A1 Sulptionamide compounds that modulate chemokine receptor activity (ccr4)
03/15/2006EP1633729A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
03/15/2006EP1633726A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
03/15/2006EP1633723A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
03/15/2006EP1633717A1 New p2x7 receptor antagonists and their use
03/15/2006EP1633715A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
03/15/2006EP1633714A1 2-amino-pyridine derivatives as beta-2 adrenoreceptor agonists
03/15/2006EP1633707A1 1- (alkylaminoalkyl-pyrolidin-/piperidinyl) -2, 2-diphenylacetamide derivatives as muscarinic receptor antagonists
03/15/2006EP1633376A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
03/15/2006EP1633369A1 Process to minimize loss through adhesion to equipment surfaces
03/15/2006EP1633359A1 Use of efletirizine for treating persistent allergic rhinitis
03/15/2006EP1521595B1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase
03/15/2006EP1513834B1 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
03/15/2006EP1492797B1 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof
03/15/2006EP1448566B1 Chemokine receptor antagonists and methods of use thereof
03/15/2006EP1408962B1 Substituted isoindoles and the use thereof
03/15/2006EP1403249B1 Cyclic diamine compounds bearing six-membered cyclic groups
03/15/2006EP1326864B1 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
03/15/2006EP1324749B1 Medicinal aerosol formulations
03/15/2006EP1309593B1 Substituted pyrazoles
03/15/2006EP1289992B1 New crystalline form of a triazolo(4,5-d)pyrimidine compound
03/15/2006EP1196172B1 (S,S)-Reboxetine for treating chronic pain
03/15/2006EP1063885B1 Xylitol compositions for treating upper respiratory conditions
03/15/2006EP0929554B1 Spiro-azacyclic derivatives, their preparation and their use as tachykinin antagonists
03/15/2006CN1747728A Compositions and methods for improving the condition of patients suffering from copd and other diseases
03/15/2006CN1747725A Compositions and methods for treating upper respiratory congestion.
03/15/2006CN1746183A Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity
03/15/2006CN1746181A Coronavirus specific T-cellantigen determinate cluster
03/15/2006CN1745834A Chinese medicinal composition for treating asthma, and its preparation and use
03/15/2006CN1745832A Infantile antasthmatic
03/15/2006CN1745815A Compound Chinese medicine for treating pharyngolaryngitis
03/15/2006CN1745785A Jizhi solid preparation
03/15/2006CN1745784A Chinese medicinal composition for treating upper respiratory tract infection
03/15/2006CN1745774A Chinese medicinal preparation for treating pharyngolaryngitis and its making method thereof
03/15/2006CN1745635A Water-base long-effective sanitary insecticide
03/15/2006CN1245496C Preparation method of chinese caterpillar fungus wine
03/15/2006CN1245405C Piperazine derivatives
03/15/2006CN1245376C Substituted 2-dialkylamino alkylbiphenyl derivatives
03/15/2006CN1245204C Medicine for curing acute pharyngitis and its preparing method
03/15/2006CN1245195C Traditional Chinese medicine composition for treating SARS and preparation process thereof